|Bid||13.30 x 1400|
|Ask||0.00 x 1300|
|Day's Range||15.04 - 15.50|
|52 Week Range||5.55 - 24.95|
|Beta (5Y Monthly)||1.35|
|PE Ratio (TTM)||24.29|
|Earnings Date||Oct 28, 2020 - Nov 02, 2020|
|Forward Dividend & Yield||1.20 (7.74%)|
|Ex-Dividend Date||May 15, 2020|
|1y Target Est||14.29|
Sabra (SBRA) delivered FFO and revenue surprises of 12.50% and 5.24%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (Nasdaq:SBRA) today announced results of operations for the second quarter of 2020 and provided a business update.
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company’s Chairman and Chief Executive Officer, Harold Andrews, the company’s Chief Financial Officer, Talya Nevo-Hacohen, the company’s Chief Investment Officer, and Michael Costa, the company’s Executive Vice President, Finance will participate in a Virtual Investor Access Offering hosted by MUFG Union Bank on August 12, 2020.